Sudeep Pharma IPO Subscription
ListedUpdated 28 November 2025, 9:15 AM IST· Mainboard
Sudeep Pharma IPO subscription closed on 25 November 2025 at 93.71x overall by shares. QIB demand came in at 213.08x, NII at 116.72x, and retail at 15.65x. See Retail, SHNI, and BHNI allotment chances in the table below.
Allotment date is 26 November 2025. Listing date on NSE and BSE is 28 November 2025.
Sudeep Pharma IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 21 Nov 2025 | 0.09x | 3.01x | 1.53x | 1.43x |
| Day 2 - 24 Nov 2025 | 0.13x | 12.03x | 5.02x | 5.13x |
| Day 3 - 25 Nov 2025 | 213.08x | 116.72x | 15.65x | 93.71x |
Sudeep Pharma IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Sudeep Pharma IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail | 12.89x | 1 in 13 |
| SHNI (Rs 2L to Rs 10L) | 76.28x | 1 in 76 |
| BHNI (above Rs 10L) | 27.29x | 1 in 27 |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the Sudeep Pharma IPO Allotment Status page from 26 November 2025 for your result.
Sudeep Pharma IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 593.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 179.00 Cr | Rs 38,141.08 Cr | 213.08x |
| FII | - | Rs 11,221.95 Cr | - |
| DFI | - | Rs 15,279.16 Cr | - |
| Mutual Funds | - | Rs 1,698.70 Cr | - |
| Other | - | Rs 9,941.26 Cr | - |
| NII | Rs 134.25 Cr | Rs 15,669.46 Cr | 116.72x |
| bNII (above Rs 10L) | Rs 89.50 Cr | Rs 12,074.65 Cr | 134.91x |
| Corporate | - | Rs 91.56 Cr | - |
| Individual | - | Rs 11,377.32 Cr | - |
| Other | - | Rs 605.77 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 44.75 Cr | Rs 3,594.81 Cr | 80.33x |
| Corporate | - | Rs 7.29 Cr | - |
| Individual | - | Rs 3,425.07 Cr | - |
| Other | - | Rs 162.45 Cr | - |
| Retail | Rs 313.25 Cr | Rs 4,902.41 Cr | 15.65x |
| Cut-off price | - | Rs 4,029.44 Cr | - |
| Fixed price | - | Rs 872.97 Cr | - |
| Total | Rs 626.50 Cr | Rs 58,712.94 Cr | 93.72x |
Sudeep Pharma IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 30,18,553 | 2,529 | 0.00x |
| FII | - | 93 | - |
| DFI | - | 54 | - |
| Mutual Funds | - | 24 | - |
| Other | - | 2,358 | - |
| NII | 6,468 | 2,82,125 | 43.62x |
| bNII (above Rs 10L) | 4,312 | 1,17,658 | 27.29x |
| Corporate | - | 852 | - |
| Individual | - | 1,10,892 | - |
| Other | - | 5,914 | - |
| sNII (Rs 2L to Rs 10L) | 2,156 | 1,64,467 | 76.28x |
| Corporate | - | 315 | - |
| Individual | - | 1,56,557 | - |
| Other | - | 7,595 | - |
| Retail | 2,11,298 | 27,23,404 | 12.89x |
| Cut-off price | - | 22,36,468 | - |
| Fixed price | - | 4,86,936 | - |
| Total | 32,36,319 | 30,08,058 | 0.93x |
What Do These Subscription Numbers Mean?
93.71x overall by shares means bids covered about 94 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 213.08x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (43.62x by applications). Split: SHNI 76.28x, BHNI 27.29x by applications. SHNI and BHNI allotment is by lottery.
At 12.89x subscription by applications, about 1 in 13 retail applicants may get allotment (~8% chance per application). Retail allotment is also by lottery.
Sudeep Pharma IPO GMP After Subscription
GMP for Sudeep Pharma IPO stands at Rs 121.00 today, giving an estimated listing price of Rs 714.00 per share.
A subscription of 93.71x combined with a GMP of 20.40% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Sudeep Pharma IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Sudeep Pharma IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 21 November 2025 |
| IPO Close Date | 25 November 2025 |
| Allotment Date | 26 November 2025 |
| Refund Initiation | 27 November 2025 |
| Share Credit to Demat | 27 November 2025 |
| Listing Date | 28 November 2025 |
| Minimum Investment | Rs 14,825.00 |
| Lot Size | 25 shares |
About Sudeep Pharma IPO
Sudeep Pharma is a technology-led manufacturer of **excipients** and **specialty mineral ingredients** used globally in pharmaceutical, food, and nutrition industries. The company utilizes in-house technologies such as encapsulation, spray drying, and liposomal preparations to produce high-value mineral-based ingredients (calcium, iron, zinc, etc. ).
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Sudeep Pharma IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Sudeep Pharma IPO Details
Issue size, price, financials, and company info
Sudeep Pharma IPO GMP
Live grey market premium and listing estimate
Sudeep Pharma IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Sudeep Pharma IPO Allotment
Allotment date, chances, and check by PAN
Sudeep Pharma IPO Review
SWOT, strengths, risks, and IPO review
Sudeep Pharma IPO FAQ
Common questions on dates, GMP, and allotment
Sudeep Pharma IPO Registrar
Registrar website and how to check allotment
Sudeep Pharma IPO Timeline
Open, close, allotment, and listing dates
Sudeep Pharma IPO News
Updates, blogs, and latest IPO news
Sudeep Pharma IPO Subscription FAQs
What is Sudeep Pharma IPO subscription status today?
Sudeep Pharma IPO subscription closed on 25 November 2025 with overall subscription of 93.71x (by shares) as of 27 August 2026, 4:32 AM IST. QIB 213.08x, NII 43.62x, Retail 12.89x.
What is the overall subscription of Sudeep Pharma IPO?
Sudeep Pharma IPO is subscribed 93.71x overall by shares at close on 25 November 2025. QIB 213.08x, NII 43.62x, and Retail 12.89x.
What is Sudeep Pharma IPO QIB subscription?
Sudeep Pharma IPO QIB (Qualified Institutional Buyers) subscription is 213.08x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Sudeep Pharma IPO Retail subscription?
Sudeep Pharma IPO Retail subscription is 12.89x by applications. Retail bids are up to Rs 2 lakh per PAN.
What is Sudeep Pharma IPO NII, SHNI, and BHNI subscription?
Sudeep Pharma IPO NII subscription is 43.62x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 76.28x and BHNI (above Rs 10L) at 27.29x.
What are Sudeep Pharma IPO retail allotment chances?
At 12.89x subscription by applications, about 1 in 13 retail applicants may get allotment (~8% chance per application). Allotment is by lottery. Share subscription was 15.65x. Allotment chances use applications, not share volume.
What are Sudeep Pharma IPO SHNI allotment chances?
At 76.28x subscription by applications, about 1 in 76 SHNI applicants may get allotment (~1% chance per application). Allotment is by lottery. Share subscription was 80.33x. Allotment chances use applications, not share volume.
What are Sudeep Pharma IPO BHNI allotment chances?
At 27.29x subscription by applications, about 1 in 27 BHNI applicants may get allotment (~4% chance per application). Allotment is by lottery. Share subscription was 134.91x. Allotment chances use applications, not share volume.
When is Sudeep Pharma IPO allotment date?
Sudeep Pharma IPO allotment date is 26 November 2025. Check Sudeep Pharma IPO Allotment Status on IPOwiz from that day using your PAN.
When does Sudeep Pharma IPO subscription close?
Sudeep Pharma IPO subscription closed on 25 November 2025. No new applications are accepted after the close.
What is Sudeep Pharma IPO GMP today?
Sudeep Pharma IPO GMP is ₹121 today (+20.40% over issue price ₹593). See live GMP on the Sudeep Pharma IPO GMP Today page.
What is Sudeep Pharma IPO issue price and lot size?
Sudeep Pharma IPO issue price is ₹593 per share. Lot size is 25 shares. Minimum investment is ₹14,825 per lot. Issue size: ₹895.00 Cr.
When is Sudeep Pharma IPO listing date?
Sudeep Pharma IPO listing date is 28 November 2025 on NSE and BSE. Allotment is on 26 November 2025.
How does subscription affect Sudeep Pharma IPO allotment?
In Sudeep Pharma IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 93.71x overall, competition is very high.
For allotment results from 26 November 2025, visit the Sudeep Pharma IPO Allotment Status page. For listing day updates on 28 November 2025, download the IPOwiz App.
Sources
We match Sudeep Pharma IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.